# Autonomic Neuropathy, GI Motility, and Inflammation in HIV

> **NCT02850276** · EARLY_PHASE1 · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 76 (actual)

## Conditions studied

- HIV Disease

## Interventions

- **DRUG:** Pyridostigmine

## Key facts

- **NCT ID:** NCT02850276
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2018-06-01
- **Final completion:** 2018-06-01
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2019-05-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02850276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02850276, "Autonomic Neuropathy, GI Motility, and Inflammation in HIV". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02850276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
